Zymeworks Presents Results of the Completed Dose Escalation Portion of the Ongoing Phase 1 Study of ZW25 at the San Antonio Breast Cancer Symposium
Stock Information for Zymeworks Inc.
Loading
Please wait while we load your information from QuoteMedia.